> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Remote Regulatory Assessment Q&A Guidance
- URL: https://www.fdaweb.com/remote-regulatory-assessment-q-a-guidance/
- Published: 2025-06-26T12:00:00.000Z
- Updated: 2026-09-14T15:15:17.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5159425

FDA has published a guidance, *Conducting Remote Regulatory Assessments—Questions and Answers*, to help enhance the industry’s understanding of such assessments, thus facilitating the process for FDA conducting the assessments. The [document](https://www.fda.gov/media/160173/download?ref=fdaweb.com) says the term Remote Regulatory Assessment (RRA) is used to describe a category of activities for which FDA may use different terminologies, but that are all considered to be types of RRAs, including remote interactive evaluations and remote record reviews.

Based on its experience during the Covid-19 pandemic, the guidance says, FDA has noted the value of RRAs and concluded that they are a beneficial oversight tool outside the Covid-19 pandemic and for a range of FDA-regulated products.

The guidance finalizes a 1/26/2024 revised draft guidance.